Literature DB >> 15227167

After thrombolytic therapy: angiography, angioplasty, or surgery?

M L Stadius1.   

Abstract

Thrombolytic therapy has been found to improve the prognosis of selected patients with acute myocardial infarction. Many investigators advocate that combined emergency coronary angiography and percutaneous transluminal coronary angioplasty be performed immediately after thrombolytic therapy. Emergency angiography documents the anatomic extent of coronary artery disease, shows whether reperfusion has occurred, and indicates whether emergency angioplasty is necessary. In this setting, emergency catheterization without angioplasty is associated with relatively little additional risk. However, a number of prospective trials have compared emergency angioplasty to more conservative treatment strategies, and emergency angioplasty has been not found to offer any advantage in terms of improved prognosis or preservation of left ventricular function. Therefore, it is probable that most patients with evolving Q-wave myocardial infarction are best treated with conservative strategies after initial thrombolytic therapy, although there may still be a role for emergency angioplasty in a relatively small subset who present with evolving myocardial infarction and severely depressed left ventricular function. Emergency coronary artery bypass surgery also appears to have a limited role in patients treated with thrombolytic therapy. Nevertheless, in occasional patients with a poor prognosis at hospital presentation, in whom thrombolytic therapy and emergency angioplasty have failed or are contraindicated, prompt emergency coronary artery bypass grafting may salvage the ischemic myocardium and improve the prognosis.

Entities:  

Year:  1990        PMID: 15227167      PMCID: PMC324913     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  22 in total

1.  Reperfusion protocol and results in 738 patients with evolving myocardial infarction.

Authors:  S J Phillips; R H Zeff; J R Skinner; R S Toon; A Grignon; C Kongtahworn
Journal:  Ann Thorac Surg       Date:  1986-02       Impact factor: 4.330

2.  Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands.

Authors:  M L Simoons; P W Serruys; M vd Brand; F Bär; C de Zwaan; J Res; F W Verheugt; X H Krauss; W J Remme; F Vermeer
Journal:  Lancet       Date:  1985-09-14       Impact factor: 79.321

3.  Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction.

Authors:  R S Stack; R M Califf; T Hinohara; H R Phillips; D B Pryor; C A Simonton; E B Carlson; K G Morris; V S Behar; Y Kong
Journal:  J Am Coll Cardiol       Date:  1988-06       Impact factor: 24.094

4.  Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris.

Authors:  P Rentrop; H Blanke; K R Karsch; H Kaiser; H Köstering; K Leitz
Journal:  Circulation       Date:  1981-02       Impact factor: 29.690

Review 5.  Platelet inhibitor agents in cardiovascular disease: an update.

Authors:  B Stein; V Fuster; D H Israel; M Cohen; L Badimon; J J Badimon; J H Chesebro
Journal:  J Am Coll Cardiol       Date:  1989-10       Impact factor: 24.094

6.  A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction.

Authors:  R H Leiboff; R J Katz; A G Wasserman; G B Bren; H Schwartz; P J Varghese; A M Ross
Journal:  Am J Cardiol       Date:  1984-02-01       Impact factor: 2.778

7.  Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.

Authors:  F Van de Werf; P A Ludbrook; S R Bergmann; A J Tiefenbrunn; K A Fox; H de Geest; M Verstraete; D Collen; B E Sobel
Journal:  N Engl J Med       Date:  1984-03-08       Impact factor: 91.245

8.  Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty.

Authors:  M L Simoons; A E Arnold; A Betriu; D P de Bono; J Col; F C Dougherty; R von Essen; H Lambertz; J Lubsen; B Meier
Journal:  Lancet       Date:  1988-01-30       Impact factor: 79.321

9.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

Authors:  M A DeWood; J Spores; R Notske; L T Mouser; R Burroughs; M S Golden; H T Lang
Journal:  N Engl J Med       Date:  1980-10-16       Impact factor: 91.245

10.  Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. The Western Washington Intracoronary Streptokinase Trial.

Authors:  M L Stadius; K Davis; C Maynard; J L Ritchie; J W Kennedy
Journal:  Circulation       Date:  1986-10       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.